Cantai Therapeutics

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://cantaitx.com/

Last Round

Seed

Nov 20, 2023

Company Overview

Cantai Therapeutics is a biotechnology company that develops cytokine-targeting bispecific antibodies for the treatment of autoimmune and inflammatory disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

bispecific antibodiesvirtual biotechdrug discoveryautoimmune therapyantibody engineeringprotein engineeringAI drug discoveryin silico designbiotech startuptherapeutic pipelinepreclinical researchcomputational biologypharma R&Dbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cantai Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Cantai Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cantai Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 20, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Ross Leimberg

COO and interim CEO

Executive Team

Cantai Therapeutics Investors

Notable investors and investment history

Cantai Therapeutics investors
Investor	Rounds
Agent Capital	Seed
Tellus BioVentures	Seed
82VS	Seed

View all Investors

Cantai Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cantai Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cantai Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range5

Year Founded2023

Last FundingNov 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.